I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Casadei Gardini, A.
580
results:
Search for persons
X
Format
Online (580)
Mediatypes
Articles (Online) (226)
Bookchapter (Online) (2)
OpenAccess-fulltext (352)
Languages
english (573)
italian (1)
Sorted by: Relevance
Sorted by: Year
?
1
287P Association of progression-free survival (PFS) with ov..:
Castet, F.
;
Fabregat-Franco, C.
;
Kim, J.W.
...
Annals of Oncology. 35 (2024) - p. S121 , 2024
Link:
https://doi.org/10.1016/..
?
2
292P Extended molecular profiling (EMP) and access to targe..:
Genovesi, V.
;
Rimini, M.
;
Pressiani, T.
...
Annals of Oncology. 35 (2024) - p. S123 , 2024
Link:
https://doi.org/10.1016/..
?
3
65P Atezolizumab plus bevacizumab versus lenvatinib for unr..:
Rimini, M.
;
Casadei Gardini, A.
;
Persano, M.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100170 , 2022
Link:
https://doi.org/10.1016/..
?
4
111P Identification of atezolizumab plus bevacizumab progno..:
Persano, M.
;
Rimini, M.
;
Cascinu, S.
..
Immuno-Oncology and Technology. 16 (2022) - p. 100215 , 2022
Link:
https://doi.org/10.1016/..
?
5
108P Role of the prognostic nutritional index in predicting..:
Persano, M.
;
Rimini, M.
;
Cascinu, S.
..
Immuno-Oncology and Technology. 16 (2022) - p. 100212 , 2022
Link:
https://doi.org/10.1016/..
?
6
67P Real-world data for atezolizumab plus bevacizumab in un..:
Persano, M.
;
Rimini, M.
;
Tada, T.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100172 , 2022
Link:
https://doi.org/10.1016/..
?
7
78P Clinical outcomes with atezolizumab plus bevacizumab (A..:
Persano, M.
;
Rimini, M.
;
Cascinu, S.
..
Immuno-Oncology and Technology. 16 (2022) - p. 100182 , 2022
Link:
https://doi.org/10.1016/..
?
8
PO-1214 Toxicity profile of adjuvant hypofractionated Image..:
SLIM, N.
;
Pacifico, P.
;
Passoni, P.
...
Radiotherapy and Oncology. 161 (2021) - p. S1005-S1006 , 2021
Link:
https://doi.org/10.1016/..
?
9
PO-1212 Outcome of adjuvant hypofractionated radiotherapy c..:
Slim, N.
;
Pacifico, P.
;
Passoni, P.
...
Radiotherapy and Oncology. 161 (2021) - p. S1004-S1005 , 2021
Link:
https://doi.org/10.1016/..
?
10
EP-1487: The prognostic role of haemoglobin in patients und..:
Martini, S.
;
Iorio, G.C.
;
Franco, P.
...
Radiotherapy and Oncology. 127 (2018) - p. S806-S807 , 2018
Link:
https://doi.org/10.1016/..
?
11
EP-1461: Immune inflammation indicators in anal cancer pati..:
Franco, P.
;
Montagnani, F.
;
Arcadipane, F.
...
Radiotherapy and Oncology. 127 (2018) - p. S793-S794 , 2018
Link:
https://doi.org/10.1016/..
?
12
Treatment of squamous cell carcinoma of the anal canal: A n..:
Casadei Gardini, A.
;
Passardi, A.
;
Fornaro, L.
...
Critical Reviews in Oncology/Hematology. 123 (2018) - p. 52-56 , 2018
Link:
https://doi.org/10.1016/..
?
13
Immune Inflammation Indicators Predict Outcome in Anal Canc..:
Franco, P.
;
Montagnani, F.
;
Arcadipane, F.
...
International Journal of Radiation Oncology*Biology*Physics. 102 (2018) 3 - p. e5-e6 , 2018
Link:
https://doi.org/10.1016/..
?
14
Validation of a simple scoring system to predict sorafenib ..:
Tortora, R.
;
Casadei Gardini, A.
;
Cordone, G.
...
Digestive and Liver Disease. 49 (2017) 1 - p. e42 , 2017
Link:
https://doi.org/10.1016/..
?
15
Ang-2 polymorphisms in relation to outcome in advanced HCC ..:
Marisi, G.
;
Scartozzi, M.
;
Faloppi, L.
...
Digestive and Liver Disease. 49 (2017) 1 - p. e19 , 2017
Link:
https://doi.org/10.1016/..
1-15